Latest / The BioHub - by Avetix
Episode 254 - Erick Lucera (CFO) & Vikram Ranade (CBO) at Dyne Therapeutics
Today, we’re joined by Erick Lucera, Chief Financial Officer, and Vikram Ranade, Chief Business Officer at Dyne Therapeutics. We’ll be discussing their individual journeys through biotech, what attracted them to Dyne, and the company’s mission to develop transformative treatments for people living with genetically driven neuromuscular diseases. We’ll also explore the strategy behind building a biotech towards commercialisation, the financial and business development challenges involved, and their perspectives on the wider biotech landscape.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.